Recently，Novo and Nord、Novartis exposes layoffs。Starting in 2011，The biomedical industry has set off a layoff storm，Reported saying，Only in 2011-3，The top 10 pharmaceutical giants in the world have an average of 30,000 people for layoffs per year。Since then, the layoff storm has become more and more trend，Glaxo Sonsk、Beltay Schimi Treasure、Roche Xuan、Johnson & Johnson and others all exposed a lot of news about layoffs，The Chinese market is no longer a sheltering harbor。

 

  21st Century Economic Herald Reporter sorted out the main reasons for layoffs of multinational pharmaceutical companies since 2011，The patented cliff arrives、Slow development of new drugs，frequent mergers and acquisitions of pharmaceutical companies; from the perspective of the department，The troops of multinational pharmaceuticals are mainly concentrated in research and development and market。

 

  For cost control，The production line with poor profitability is a common means of foreign pharmaceutical companies in China。Analysis of Wang Xin, President of the Greater China of Fhston Shaliwen，As the patent of the drug expires、Rise of domestic pharmaceutical companies、China's pharmaceutical market policy change，multinational pharmaceutical companies are facing severe revenue My stake betting apppressure，Stake Sports BettingFuture，Reasonable layoffs are still inevitable。

 

  The tide of troops of multinational pharmaceutical companies

 

  On the evening of September 29，About 1,000 layoffs were announced by Dantino and Nord to cut costs。October 9，21st Century Economic Herald reporter confirmed this news to Nuo and Nord again。

 

  Novo Nord said，Company's global current 42,300 employees，This plan is about 1,000 people，Involved in the global R & D department、The functional department of the headquarters and global business operations。Where，About 500 affected employees are from Danish。Danuo and Nord's operations in China will not be affected。

 

  Point out to point out，The above -mentioned layoffs reflect the company's current pressure in the insulin market。

 

  This，Nova Nord said to the 21st Century Business Herald reporter，Because Novo and Nord are facing intensified competition and price pressure in the US market，Therefore, we need to take measures to reduce expenditure，and this reduction is one of the measures to reduce expenditure，The number of affected people accounts for about 2%of the world's 42,300 employees。It will not affect the performance of Novo and Noord in China。

 

  Uniqueness，Following August this year announced the closure of cells and gene therapy departments，120 people、280 people have been integrated into the Nuohua tumor business department，October 6，Novartisan again，21st Century Business Herald reporter also confirmed this information to Novartis。

 

  It is understood，Novartis will close the biological preparation department located in Shanghai and Swiss Switzerland，Where，The dismissal of the Shanghai Biological Division Department involves 18 positions，The closure of 73 positions in the Switzerland's Schlilen Biopharmaceutical Department，Tropical Disease Research Center moved from Singapore to California in the United States and involved 84 positions will be dismissed。Nuohua said，The decision to make a decision is due to the reduction of expenses and strengthening research and development collaborative benefits。

 

  Starting in 2011，The biomedical industry has set off a layoff storm，Statistics display，2011-2013 Global 10 major pharmaceutical stake betting appgiants to lay off as many as My stake betting app30,000 people per year，And there is an intense momentum。

 

  According to incomplete statistics，From November 2013 to March 2015，Grammomosk's six layoffs of nearly 1,000 people; at the end of 2014，The layoff plan of Beltay Schimibao is almost covered with all the business departments of China，The number of layoffs is nearly 1,000; in 2015, Roche announced that it will close the United States、Irish、Four small molecular drug production bases in Italy and Spain，1200 people; early 2016，Johnson & Johnson announced that in the next two years, the global medical device department will lay off about 3,000 people，accounts for 4%-6%of the total number of employees in the department in the department。

 

  Analysis of Wang Xin，From the perspective of the department，multinational pharmaceutical companies are mainly in R & D and marketing departments，The former originated from adjusting the research and development strategy，Including new areas with more promising prospects and the old areas of integrated business atrophy; the latter is the root cause of the pharmaceutical company's market promotion model and the adjustment of key product lines，For example, more hired medical affairs staff，Reduce the number of sales representatives，Personnel configuration of increased key products，Reduce other personnel。

 

  21st Century Economic Herald reporters sorted out the main reasons for the layoffs of multinational pharmaceutical companies since 2011，The patented cliff arrives、Slow development of new drugs，Frequent mergers and acquisitions from pharmaceutical companies。

 

  Where，Patent expiration is one of the main reasons for the layoffs of the pharmaceutical industry。In 2011, the total layoffs of the top 10 companies in the pharmaceutical industry due to patented drugs were 26,500 people.。Follow -up also has multiple multinational pharmaceutical companies due to patent layoffs，If November 2015，Roche closed the United States、Irish、Four small molecular drug production bases in Italy and Spain，1200 people。Data display，Its small molecular drugs such as the Patey patent expires in the expiration of sales can be reduced by 90%。

 

  China is no longer a shelter

 

  China has been regarded as the best shelter of multinational pharmaceutical companies，Global Data Research Consulting Company Data Display，By 2020，China's pharmaceutical market value will skyrocket from US $ 48 billion in 2012 to $ 315 billion。

 

  stake online sports bettingBut with the changes in domestic Stake Sports Bettingbidding policies and the intensification of competition，Slows on the growth rate of multinational pharmaceutical companies in the Chinese market，Large -scale layoffs continue to appear。2013 GlaxoSmith's commercial bribery case has become a sign of the tightening of foreign pharmaceutical companies in China; at the same time，GlaxoSmith is also one of the most layoffs in China。According to incomplete statistics，From November 2013 to March 2015，Grammomosk Six Six layoffs。

 

  Shi Lichen, the person in charge of Beijing Dingchen Medical Management Consultation Center, pointed out to the 21st Century Business Herald reporter，multinational pharmaceutical companies based on July 2013 GlaxoSmith's commercial bribery case as a division point，Policy tighten、Price reduction abandonment、Difficulties in the listing of new drugs，The layoffs also come with it。& ldquo; out of cost control，Destroying some production lines with poor profitability are the usual means of foreign pharmaceutical companies in China。& rdquo;

 

  Take the tender as an example，Local bidding and procurement link，Price of multinational pharmaceutical companies、Discarding phenomenon frequency。Such as 2015，Anhui Province patent medicine to hospitals below county level、The proportion of the original research drugs has been strictly regulated，Requirements do not exceed 40%; 2015，Hunan Provincial Pharmaceuticals Bidding Procurement Purchase price decreases sharply，After two rounds of offer，Maximum decrease of 50%，Many multinational pharmaceutical companies cannot tolerate huge decline to choose to abandon the bid。

 

  The overall growth rate of the industry slows down、Under the background of the power of local pharmaceutical companies in China，Dipping and selling marginal business have become a common consensus for foreign pharmaceutical companies，If February of this year，Bayer will submit its business operation rights to Shanghai Medicine, including & ldquo; Bai, Black & RDQUO;，Glaxo Sonsk also stripped the production and supply business of urinary products in China。

 

  Wang Xin thinks，As the patent of the drug expires、Rise of domestic pharmaceutical companies、Changes in China's pharmaceutical market policy，multinational pharmaceutical companies face severe revenue My stake betting apppressure，Stake Sports BettingFuture，Reasonable layoffs are still inevitable。

 

  stake online sports bettingFrom Shi Lichen's view，My stake betting appTransnational pharmaceutical companies pass through slimming，Abandon the edge department，If the purpose of Merck's layoffs not long ago is to transform the biological field faster; on the other hand，So the assets of the three giants of Novartis-GlaxoSmiths-Lilili Lili: Novartis bought tumor assets from Glaxo Sonsk，At the same time, the vaccine business is sold to Glaxo Sonsk，The two parties then set up a health joint venture; at the same time，Novartis also sold its animal health department to Lili Lili。